Vahanian & Associates Financial Planning Inc. Kala Pharmaceuticals, Inc. Transaction History

Vahanian & Associates Financial Planning Inc.

  • $24.5 Million
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022
BUY
$0.25 - $11.7 $6,514 - $304,855
26,056 Added 14.37%
207,440 $46,000
Q2 2022

Jul 27, 2022
SELL
$0.3 - $1.31 $119,758 - $522,944
-399,194 Reduced 68.76%
181,384 $54,000
Q1 2022

Apr 27, 2022
SELL
$0.61 - $1.84 $284,202 - $857,267
-465,906 Reduced 44.52%
580,578 $801,000
Q4 2021

Jan 28, 2022
BUY
$1.16 - $2.74 $1.21 Million - $2.87 Million
1,046,484 New
1,046,484 $1.27 Million

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $9.05M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Vahanian & Associates Financial Planning Inc. Portfolio

Follow Vahanian & Associates Financial Planning Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vahanian & Associates Financial Planning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vahanian & Associates Financial Planning Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email